Shanchun Huang - 31 Jan 2024 Form 4 Insider Report for Mars Acquisition Corp.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Feb 2024, 11:08:55 UTC
Prior SEC filing
02 Jan 2024
Next SEC filing
24 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Shanchun Huang

Key filing fact

Shanchun Huang filed Form 4 for Mars Acquisition Corp. on 09 Feb 2024.

Key facts

  • This page summarizes Shanchun Huang's Form 4 filing for Mars Acquisition Corp..
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 09 Feb 2024, 11:08.

Change

  • Previous filing in this sequence was filed on 02 Jan 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MARX transaction

Ordinary Share

Award

Transaction value
$0
Shares
+518,008
Change %
Price
$0.000000
Shares after
518,008
Date
31 Jan 2024
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes (i) 385,584 ordinary shares of the Mars Acquisitions Corp. (the "Issuer") at $0.000125 par value ("Ordinary Share"); (ii) 132,424 Ordinary Shares of the Issuer underlying units (each unit consisting of one Ordinary Share and one right to receive two-tenths (2/10) of one ordinary share upon the consummation of the Issuer's initial business combination.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .